2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結財政状態計算書
| | | (単位:千円) |
| 前連結会計年度 (2023年12月31日) | | 当第3四半期連結会計期間 (2024年9月30日) |
資産 | | | |
非流動資産 | | | |
有形固定資産 | 5,238,673 | | 5,480,365 |
使用権資産 | 814,513 | | 1,047,618 |
のれん | 17,261,275 | | 17,526,722 |
無形資産 | 3,690,331 | | 4,636,676 |
持分法で会計処理されている投資 | 360,821 | | 390,592 |
繰延税金資産 | 304,436 | | 268,119 |
その他の金融資産 | 3,793,224 | | 6,135,227 |
その他の非流動資産 | 23,811 | | - |
非流動資産合計 | 31,487,087 | | 35,485,323 |
| | | |
流動資産 | | | |
棚卸資産 | 2,330,622 | | 2,602,812 |
営業債権及びその他の債権 | 3,973,476 | | 4,754,445 |
その他の金融資産 | 1,577,274 | | 4,601,997 |
その他の流動資産 | 1,392,881 | | 1,254,817 |
現金及び現金同等物 | 21,633,028 | | 14,049,285 |
流動資産合計 | 30,907,282 | | 27,263,358 |
資産合計 | 62,394,370 | | 62,748,681 |
| | | |
負債及び資本 | | | |
非流動負債 | | | |
借入金 | 1,600,000 | | 1,300,000 |
リース負債 | 150,276 | | 292,393 |
繰延税金負債 | 1,173,159 | | 1,283,900 |
その他の金融負債 | 15,139,232 | | 13,613,691 |
その他の非流動負債 | 85,146 | | 75,755 |
非流動負債合計 | 18,147,815 | | 16,565,740 |
| | | |
流動負債 | | | |
営業債務及びその他の債務 | 2,064,776 | | 1,543,547 |
借入金 | 1,300,000 | | 4,600,000 |
1年内返済予定の長期借入金 | 400,000 | | 400,000 |
リース負債 | 249,158 | | 293,961 |
未払法人所得税 | 2,187,700 | | 1,222,084 |
その他の金融負債 | 49,010 | | 461,690 |
その他の流動負債 | 1,943,131 | | 1,683,938 |
流動負債合計 | 8,193,776 | | 10,205,221 |
負債合計 | 26,341,592 | | 26,770,962 |
| | | |
資本 | | | |
資本金 | 13,052,056 | | 13,223,623 |
資本剰余金 | 7,397,974 | | 6,529,063 |
自己株式 | △15,302 | | △15,302 |
利益剰余金 | 8,790,563 | | 10,095,642 |
その他の資本の構成要素 | 4,569,122 | | 3,261,272 |
親会社の所有者に帰属する持分合計 | 33,794,414 | | 33,094,300 |
非支配持分 | 2,258,363 | | 2,883,419 |
資本合計 | 36,052,778 | | 35,977,719 |
資本及び負債の合計 | 62,394,370 | | 62,748,681 |
E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2024-01-012024-09-30Q32024-12-312023-01-012023-09-302023-12-311falsefalsefalse216002023-01-012023-09-30216002023-09-30216002024-01-012024-09-30216002024-09-30216002024-11-14216002022-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002022-12-31jpigp_cor:ShareCapitalIFRSMember216002022-12-31jpigp_cor:CapitalSurplusIFRSMember216002022-12-31jpigp_cor:TreasurySharesIFRSMember216002022-12-31jpigp_cor:RetainedEarningsIFRSMember216002022-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002022-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002022-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002022-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-01-012023-09-30jpigp_cor:ShareCapitalIFRSMember216002023-01-012023-09-30jpigp_cor:CapitalSurplusIFRSMember216002023-01-012023-09-30jpigp_cor:TreasurySharesIFRSMember216002023-01-012023-09-30jpigp_cor:RetainedEarningsIFRSMember216002023-01-012023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-01-012023-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-01-012023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-09-30jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31216002023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-09-30jpigp_cor:ShareCapitalIFRSMember216002023-09-30jpigp_cor:CapitalSurplusIFRSMember216002023-09-30jpigp_cor:TreasurySharesIFRSMember216002023-09-30jpigp_cor:RetainedEarningsIFRSMember216002022-12-31216002023-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-09-30jpcrp_cor:ReportableSegmentsMember216002023-01-012023-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002023-01-012023-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002023-01-012023-09-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-09-30jpcrp_cor:ReportableSegmentsMember216002024-01-012024-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002024-01-012024-09-30jpcrp_cor:ReconcilingItemsMember216002023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure